RecruitingNCT04838171
Prospective Study of White Blood Cells
Investigation of White Blood Cells to Support the Development of Engineered Regulatory T Cell (Treg) Therapies
Sponsor
Quell Therapeutics Limited
Enrollment
10 participants
Start Date
Mar 24, 2021
Study Type
OBSERVATIONAL
Conditions
Summary
The purpose of this study is to investigate white blood cells from volunteering donors to support the development of engineered regulatory T cell therapies.
Eligibility
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
OTHERWhite blood cell and blood collection
Mononucleocytes will be collected via apheresis
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT04838171
Related Trials
Deciphering the Genetic Architecture of Autoimmune Diseases
NCT069481102 locations
PROPULSION SANTE: Inflammometry to Improve the Diagnostic Trajectory in Situations of Suspected Asthma in Children and Adults
NCT069811693 locations
Diagnosis and Management of Inflammatory and Infectious Diseases
NCT005577261 location
Randomized, Double-blind Crossover Trial Comparing Low-GI Functional vs. Standard Wholegrain Carbohydrates on Glycolipid Metabolism and Vascular Stress Markers in Adults With Suboptimal Triglyceridemia
NCT071987891 location
Preoperative Sleep Quality and Postoperative Outcomes in Breast Surgery
NCT075477741 location